Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria
Research output: Contribution to journal › Letter › Research › peer-review
Documents
- Fulltext
Final published version, 347 KB, PDF document
Original language | English |
---|---|
Journal | Clinical and Experimental Allergy |
Volume | 53 |
Issue number | 12 |
Pages (from-to) | 1318-1321 |
ISSN | 0954-7894 |
DOIs | |
Publication status | Published - 2023 |
ID: 373887988